GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
XIII Remake was released in November 2020 and suffered a lot of criticism for the chosen art style. After Microids and PlayMagic offer “the most sincere apologies” for what happened just days after the premiere, finally, a fix is on the way. A detailed Steam patch with improvements will arrive on September 13th.

Comments about the game's performance and visuals not being true to the PS2 original had an effect. Microids handed over the title to French studio Tower Five, which retouched the work, bringing improvements to opponent AI, changes to menus, revamped sound quality and 60 FPS on PS5.

Along with these changes, an online mode for up to 13 people will also be part of the update. This feature was promised shortly after the game's release and, finally, the companies tried to talk about the functionality.

It is worth remembering, XIII Remake will run at 60 FPS on PS5, but will continue to run via backwards compatibility — its native version is on PS4. Now, we can only wait to find out how this update will impact gameplay.

More about XIII Remake:

XIII was released in 2003 for PS2, Xbox and Gamecube. In the narrative, players play as XIII, a man with no identity who finds himself in the middle of a political conflict after the death of Sheridan, the US president.

His mission, after waking up without remembering much, is to find out if he played an important role in the murder and unravel a haunting conspiracy.
GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
The J-7 fighter jet belonging to the People's Liberation Army Air Force crashed, according to reports from Chinese media. The location of the fall was determined to be Lao Hekou district, Xiangyang city, Hubei province, China.

The incident took place during a training flight yesterday's morning (June 9), the scene recorded the plane crashing, destroying houses, 2 people were unfortunately injured and 1 person died, the pilot alone. was lucky to get out of the plane earlier.

CCTV reported that the pilot was quickly taken by medical staff to the hospital for treatment with other injured people. The case is still under investigation.

This is not the only case of an accident while training a plane. As noted, in 2015 there was a similar fighter plane crash, the pilot promptly shot out of the cockpit before the fighter crashed down the hillside.

Two years earlier, another pilot was killed when a fighter jet crashed during night training in eastern Zhejiang.

GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
The first trailer for Netflix 's Resident Evil series has finally been released. The streaming giant is presenting several news at Geeked Week and Capcom's franchise, adapted for the service, had snippets of the plot shown there. The premiere will take place on July 14.

Umbrella corporation will change the world! Based on the horror franchise, Resident Evil and the T-Virus will arrive on Netflix on July 14th.

Netflix's Resident Evil narrative will show Billie and Jade, two young women new to the new Raccoon City, in the year 2022. As highlighted in the trailer above, the metropolis will collapse, and part of the story will take place in the year 2036.

Netflix's Resident Evil Will Have Eight Episodes:

Netflix's Resident Evil series will hit the streaming catalog with eight episodes at once. Each of the chapters will be about 1 hour long and the story, as noted above, will be divided into two parts/timelines.

In the first, Jade and Billie Wesker will move to Raccoon and somehow get involved with the corporation's secrets. In the second, set in 2036, the result of the catastrophe will be the focus.
GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
Many movies have age restrictions, and audiences will be asked to provide relevant documents to testify before admission. Since there is no culture in the UK to carry an ID card when going out, most citizens will use a driver's license as an identification document, which makes young people without a driver's license often inconvenient because they forget to bring their ID card.

Therefore, the British start-up company Yoti launched an electronic ID card system, hoping to provide a new way of identification for young people without a driving license. Users simply download the Yoti app from the Apple App Store or Android Play, and scan their ID card into the app with a camera.

Yoti has reached an agreement with The UK Cinema Association, which covers more than 90% of local cinemas, to allow young people aged 13 or over to use Yoti's digital ID as proof of identity in cinemas of members of the association.

Teens can prove their age without an ID card by simply showing their age information in the Yoti app at the theater box office, or by having the staff scan their Yoti ID.

Phil Clapp, chief executive of the British Theatre Association, believes young people will be frustrated by being kicked out of theatres for failing to provide proof of identity, and even increase their friction with theatre staff.

Robin Tombs, CEO and co-founder of Yoti, expressed the hope that Yoti's e-ID card can provide a simple identification document for young people, describing Yoti as a win-win situation for both theaters and young audiences.
GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
Cancer is a disease ranked among the most difficult to cure in the world because of its complex nature. That's why these treatments are also notoriously "barbaric" to the body itself, as it often attacks both healthy cells and tumor cells, causing a multitude of side effects.

Immunotherapies that help the immune system recognize and attack cancer cells do the same. Although there have been countless patients whose lives have been extended, in reality they only work for a small number of patients. One study found that less than 30% of breast cancer patients responded to one of the most common forms of immunotherapy.

But what if we could engineer new drugs that attack only tumor cells and avoid the healthy rest of the body?

The Promise of IL-12:

Researchers at the University of Chicago's Pritzker School of Molecular Engineering have designed a method to create such a promising cancer drug. As many of us may already know, Cytokines are proteins that can regulate how the immune system responds to threats. One way they do that is to activate "killer" T cells, a type of white blood cell that can attack cancer cells. Because cytokines can train the immune system to destroy tumours, this makes them very promising as a cancer treatment.

Current cancer treatments are inadvertently destroying healthy cells One such cytokine is interleukin-12, abbreviated IL-12. Although discovered more than 30 years ago, IL-12 is still not an FDA-approved therapy for cancer patients because of its serious side effects, such as liver damage. This is partly because IL-12 instructs immune cells to produce large amounts of inflammatory molecules that can harm the body. Now, however, researchers have been working to improve IL-12 to be more tolerable while retaining its powerful cancer-killing effects.

"Massed Assassin"

To create a safer version of IL-12, the team of researchers took advantage of one of the key differences between healthy and cancerous tissue: an excess of growth-promoting enzymes in cancer. . It is a fact that cancer cells multiply very quickly, they overproduce certain enzymes that help them invade nearby healthy tissues and metastasize to other parts of the body. Healthy cells grow at a much slower rate and produce fewer enzymes. With this data, the scientists "masked" IL-12 with a mask that covers the part of the molecule that normally binds with immune cells to activate them.

Their camouflage is only removed when it comes into contact with enzymes found in the vicinity of tumours. When these enzymes are cleaved, IL-12 is reactivated and prompts nearby killer T cells to attack the tumor. When the researchers applied these masked IL-12 molecules to both healthy and tumor tissue donated by melanoma and breast cancer patients, they found that only the New cancerous tumor can remove its disguise.

New drug based on "camouflage" is only activated to destroy tumors

This indicates that masked IL-12 is capable of promoting a robust immune response against tumors without causing damage to healthy organs. The team then went on to test the safety of the masked IL-12 by measuring biomarkers of liver damage in mice. They found that the immune-related side effects commonly associated with IL-12 were absent in the masked IL-12-treated mice over a period of several weeks, indicating a safe level of efficacy. improve.

In experimental models of breast cancer, masked IL-12 showed a cure rate of 90%, while treatment with a commonly used immunotherapy called a checkpoint inhibitor only yields a cure rate of 10%. In a colon cancer model, masked IL-12 showed a 100% cure rate.

The researchers' next step is to test the improved IL-12 in cancer patients. While it will take time to bring this encouraging development directly to patients, scientists believe a promising new treatment is on the way.
GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
According to Taiwan's "Economic Daily", that Foxconn's iDPBG business group under Hon Hai planned the Zhengzhou factory, and sent more than 20 cadres to Hon Hai's India factory before and after the Dragon Boat Festival to impart experience.

The outside world believes that Hon Hai's move will strengthen the layout of the Indian supply chain. Since the Zhengzhou plant is the largest production base for the iPhone, it highlights that Hon Hai is strengthening the manufacturing capacity of the iPhone in India.

The JPMorgan report believes that the forecast for the iPhone 14 stocking volume is now more conservative than that expected by the iPhone supply chain.

The iPhone 14 and iPhone 14 Pro may start mass production in early August, and the high-end iPhone 14 Pro Max will start production at the end of August. And began to expand production in early to mid-September.

Apple started production of the best-selling iPhone 13 at its Hon Hai factory near Chennai, India, in mid-April.

Apple initially produced the iPhone SE model in India in 2017, and later produced the iPhone 11 and iPhone 12, before adding the iPhone 13 in mid-April.

In the past, after Apple released the latest iPhone, it usually took 8 months to produce in India, and now it is shortened to 6-7 months.

According to reports, Apple's iPhone 14 series is expected to have four models, including the 6.1-inch iPhone 14, the 6.7-inch iPhone 14 Max, the 6.1-inch iPhone 14 Pro and the 6.7-inch iPhone 14 Pro Max.

The iPhone 14 Pro series models use a "pill + punch screen" with built-in True Depth camera and FaceTime camera; meanwhile, the lower-priced non-Pro models will continue to use the notch screen.

Other improvements expected on the iPhone 14 Pro and iPhone 14 Pro Max include a 120Hz ProMotion display and a 48MP wide-angle camera on the premium models.
GTRENDS: Giving you feeds on what's happening in America and the world at large. Be it in tech, politics, entertainment, health and sports, gaming etc
For Apple, strengthening the promotion of self-developed chips is the top priority, so the next A16 and M2 are also very popular.

The A16 chip for the iPhone will reportedly be built on the same 5nm process as the iPhone 13's A15 Bionic, while Apple will leave the bigger performance leap to the "M2" chip it designs for its next Mac.

According to sources, the A16 will use TSMC's N5P process. This suggests that the substantial upgrade of the A16 may not be as big as previously thought.

The M2 chip will apparently be the first Apple chip to upgrade to TSMC's 3nm process, skipping 4nm entirely. The M2 is believed to be Apple's first custom ARMv9 processor.

Apple is also said to be working on a "final SoC for the M1 series," which will feature an upgraded core structure. The M1, M1 Pro, M1 Max and M1 Ultra chips use energy-efficient "Icestorm" cores and high-performance "Firestorm" cores – just like the A14 Bionic chip.

Apple's last M1 variant will be based on the A15 Bionic chip, swapped for "Blizzard" energy-efficient cores and "Avalanche" high-performance cores, and this last chip in the M1 series will likely be available in the next Mac Pro.